Heidi Splete

Washington, D.C.

Journalist, Writer and Editor at Freelance

medical journalist, fitness enthusiast; managing editor, Skin & Allergy News

Featured in: Favicon

webmd.com

medscape.com (+3) Favicon

mdedge.com Favicon

practicalpainmanagement.com Favicon

khq.com

sentinelsource.com Favicon

nbcrightnow.com Favicon

appeal-democrat.com Favicon

fltimes.com Favicon

gillettenewsrecord.com + 37 more

Articles

Third Trimester Vegetable Intake May Boost Kids’ Cognition

2 weeks ago | medscape.com | Heidi Splete

Children whose mothers consumed greater amounts of polyphenols in the last trimester of pregnancy scored significantly higher on several cognitive measures at 8 years of age than children of mothers with lower polyphenol intakes in the last trimester, according to data from a new study presented at the annual meeting of the American Society for Nutrition.
Global Warming May Fuel Obstructive Sleep Apnea

2 weeks ago | medscape.com | Heidi Splete

Potential climate change scenarios could nearly double the global incidence of obstructive sleep apnea (OSA), based on estimates from a new study presented at American Thoracic Society (ATS) 2025 International Conference.
Can Rectal Cancer Patients Benefit from Deintensification of Treatment?

3 weeks ago | mdedge.com | Heidi Splete

FROM NCCN 2024New and evolving research in locally advanced rectal cancer suggests that selective use of treatments in some patients can achieve outcomes similar to those of standard regimens, according to the chair of the Department of Radiation Oncology at Duke University School of Medicine, Durham, North Carolina.
Tezepelumab Curbs Oral Corticosteroid Use in Severe Asthma

3 weeks ago | medscape.com | Heidi Splete

The addition of tezepelumab to standard treatment allowed half the adults with severe asthma to discontinue their use of oral corticosteroids (OCS) after 1 year, according to new data from nearly 300 individuals. Tezepelumab, a human monoclonal antibody, has been associated with reduction in the use of OCS in patients with OCS-dependent asthma, David J.
Beneficio en el embarazo del uso de dosis bajas de ácido acetilsalicílico

1 month ago | espanol.medscape.com | Heidi Splete

El cambio del protocolo de prescripción de ácido acetilsalicílico en dosis bajas para la prevención de la preeclampsia desde una recomendación basada en el riesgo hasta una recomendación universal aumentó significativamente el uso de ácido acetilsalicílico en pacientes embarazadas, según los nuevos datos presentados en el Congreso Anual del American College of Obstetricians and Gynecologists (ACOG) de 2025.
Newly Approved Mepolizumab Mitigates COPD Exacerbations

1 month ago | medscape.com | Heidi Splete

Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the MATINEE study presented at the American Thoracic Society (ATS) 2025 International Conference. Based on these findings, mepolizumab is newly approved by the US Food and Drug Administration for the treatment of COPD according to manufacturer GlaxoSmithKline.
Prenatal Exposure, Maternal Factors Drive Childhood BMI

1 month ago | medscape.com | Heidi Splete

Maternal factors, including high maternal prepregnancy body mass index (BMI), high weight gain during pregnancy, and smoking, were associated with an atypically high BMI trajectory in children, based on data from nearly 9500 children.
Vacinação contra vírus sincicial respiratório é associada a menos hospitalizações infantis

1 month ago | portugues.medscape.com | Heidi Splete

As taxas de hospitalização associadas ao vírus sincicial respiratório (VSR) entre bebês nos Estados Unidos foram significativamente menores no primeiro ano em que os produtos de prevenção estiveram amplamente disponíveis, segundo dados da rede de vigilância referentes ao período de 2024–2025. Durante essa temporada, foram utilizados tanto a vacina materna contra o VSR quanto o anticorpo monoclonal de ação prolongada nirsevimabe para bebês e crianças pequenas de 0 a 19 meses, escreveram a Dra.
Agências aconselham suspensão do uso da vacina contra chikungunya em adultos com 60 anos ou mais

1 month ago | portugues.medscape.com | Heidi Splete

Os profissionais de saúde devem suspender a administração da vacina viva contra chikungunya (Ixchiq) enquanto prossegue a avaliação de eventos adversos graves (neurológicos, cardíacos e outros) em pessoas vacinadas, segundo comunicado de segurança emitido em conjunto pela Food and Drug Administration (FDA) e os Centers for Disease Control and Prevention (CDC) dos Estados Unidos. Até 7 de maio de 2025, foram registrados 17 eventos adversos graves, incluindo dois óbitos.
New Criteria Pin Down Difficult-to-Manage Axial Spondyloarthritis

1 month ago | medcentral.com | Heidi Splete

A substantial number of patients with axial spondyloarthritis (axSpA) do not achieve remission or respond to treatment despite available therapies, but a new definition offers guidance to improve clinical care.